Trend Analysis Tandem Diabetes Care, Inc. (TNDM) Stock trading around $64.89...

Tandem Diabetes Care, Inc. (TNDM) Stock trading around $64.89 per share: What’s Next?


- Advertisment -

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) stock went on an upward path that rose over 1.58% on Monday, amounting to a one-week price increase of more than 7.68%. Over the last 12 months, TNDM stock rose by 50.28%. The one-year TNDM stock forecast points to a potential downside of -0.27, with the average price target set at $82.38 per share. The average equity rating for TNDM stock is currently 1.90, trading closer to a bullish pattern in the stock market.

The market cap for TNDM stock reached $3.67 billion, with 56.51 million shares outstanding and 54.01 million shares in the current float. Compared to the average trading volume of 1.28M shares, TNDM reached a trading volume of 1,020,272 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on Tandem Diabetes Care, Inc. (TNDM):

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TNDM shares is $82.38 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TNDM stock is a recommendation set at 1.90. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

BofA/Merrill have made an estimate for Tandem Diabetes Care, Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on May-17-19. While these analysts kept the previous recommendation, SVB Leerink raised their target price to Outperform. The new note on the price target was released on May-13-19, representing the official price target for Tandem Diabetes Care, Inc. stock. Previously, the target price had yet another raise to $77, while BMO Capital Markets analysts kept a Outperform rating on TNDM stock. On Mar-05-19, analysts increased their price target for TNDM shares from 59 to 65.

The Average True Range (ATR) for Tandem Diabetes Care, Inc. is set at 2.81, with the Price to Sales ratio for TNDM stock in the period of the last 12 months amounting to 13.02. The Price to Book ratio for the last quarter was 25.96, with the Price to Cash per share for the same quarter was set at 2.33. Quick ratio for the last quarter at 2.20.

TNDM Stock Performance Analysis:

Tandem Diabetes Care, Inc. (TNDM) gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.68. With this latest performance, TNDM shares dropped by -3.99% in over the last four-week period, additionally sinking by -6.15% over the last 6 months – not to mention a rise of 50.28% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TNDM stock in for the last two-week period is set at 52.58, with the RSI for the last a single of trading hit 54.81, and the three-weeks RSI is set at 51.06 for Tandem Diabetes Care, Inc. (TNDM). The present Moving Average for the last 50 days of trading for this stock 63.93, while it was recorded at 62.48 for the last single week of trading, and 58.20 for the last 200 days.

Insight into Tandem Diabetes Care, Inc. Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Tandem Diabetes Care, Inc. (TNDM) shares currently have an operating margin of -24.27 and a Gross Margin at +48.85. Tandem Diabetes Care, Inc.’s Net Margin is presently recorded at -66.68.

Return on Total Capital for TNDM is now -49.96, given the latest momentum, and Return on Invested Capital for the company is -137.25. Return on Equity for this stock declined to -240.11, with Return on Assets sitting at -81.30.

Reflecting on the efficiency of the workforce at the company, Tandem Diabetes Care, Inc. (TNDM) managed to generate an average of -$187,766 per employee. Receivables Turnover for the company is 6.57 with a Total Asset Turnover recorded at a value of 1.22. Tandem Diabetes Care, Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.20 and a Current Ratio set at 2.50.


With the latest financial reports released by the company, Tandem Diabetes Care, Inc. posted -0.62/share EPS, while the average EPS was predicted by analysts to be reported at -0.34/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -82.40%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TNDM.

Tandem Diabetes Care, Inc. (TNDM) Insider Position Details

There are presently around $3,017 million, or 85.10% of TNDM stock, in the hands of institutional investors. The top three institutional holders of TNDM stocks are: 1832 ASSET MANAGEMENT L.P. with ownership of 0, which is approximately Sold Out of the company’s market cap and around 5.14% of the total institutional ownership; A.R.T. ADVISORS, LLC, holding 38,513 shares of the stock with an approximate value of $2.46 million in TNDM stocks shares; and ADVISOR GROUP, INC., currently with $207000 in TNDM stock with ownership of nearly -81.744% of the company’s market capitalization.

Positions in Tandem Diabetes Care, Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 145 institutional holders increased their position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) by around 6,633,144 shares. Additionally, 137 investors decreased positions by around 6,155,648 shares, while 30 investors held positions by with 34,433,103 shares. The mentioned changes placed institutional holdings at 47,221,895 shares, according to the latest SEC report filing. TNDM stock had 53 new institutional investments in for a total of 2,108,720 shares, while 49 institutional investors sold positions of 1,414,777 shares during the same period.


Please enter your comment!
Please enter your name here

Latest news

Wright Medical Group N.V. (WMGI) Stock trading around $30.40 per share: What’s Next?

Wright Medical Group N.V. (NASDAQ:WMGI) stock went on a downward path that fall over -0.16% on Thursday, amounting to...

EnLink Midstream LLC (ENLC) Revenue clocked in at $6.96 billion, down -25.94% YTD: What’s Next?

EnLink Midstream LLC (NYSE:ENLC) stock went on an upward path that rose over 0.22% on Thursday, amounting to a...

SunCoke Energy Inc. (SXC) Is Currently -5.13 below its 200 Period Moving Avg: What Dose This Mean?

SunCoke Energy Inc. (NYSE:SXC) stock went on a downward path that fall over -5.13% on Thursday, amounting to a...

Murphy Oil Corporation (MUR) moved down -0.04: Why It’s Important

Murphy Oil Corporation (NYSE:MUR) stock went on a downward path that fall over -0.04% on Thursday, amounting to a...

why Mylan N.V. (MYL) is a Good Choice for Investors After New Price Target of $25.88

Mylan N.V. (NASDAQ:MYL) stock went on an upward path that rose over 0.12% on Thursday, amounting to a one-week...

Market Analysts see Uranium Energy Corp. (UEC) gaining to $3. Time to buy?

Uranium Energy Corp. (NYSE:UEC) stock went on an upward path that rose over 0.38% on Thursday, amounting to a...

Must read

why Gentex Corporation (GNTX) is a Good Choice for Investors After New Price Target of $21.92

Gentex Corporation (NASDAQ:GNTX) stock went on an upward path...

Pattern Energy Group Inc. (PEGI) Stock trading around $27.02 per share: What’s Next?

Pattern Energy Group Inc. (NASDAQ:PEGI) stock went on an...
- Advertisement -

You might also likeRELATED
Recommended to you